List your company

Survival Prediction on Overall Across Cohorts

0.629C-IndexSURVPATH
0.495880.530440.5650.59956Apr 13, 2023

Evaluation results

MethodLinks
SURVPATHModality=Multimodal, Magnification=20x2023.040.629
MLPModality=Omics, Magnification=20x, Pathway Sets=Reactome and Hallmark2023.040.599
MCATModality=Multimodal, Fusion Strategy=Early fusion, Magnification=20x, Pathway Sets=Reactome and Hallmark2023.040.594
MOTCatModality=Multimodal, Fusion Strategy=Early fusion, Magnification=20x, Pathway Sets=Reactome and Hallmark2023.040.589
TransMIL (KP)Modality=Multimodal, Fusion Strategy=Kronecker product, Magnification=20x, Pathway Sets=Reactome and Hallmark2023.040.577
ABMIL (KP)Modality=Multimodal, Fusion Strategy=Kronecker product, Magnification=20x, Pathway Sets=Reactome and Hallmark2023.040.571
TransMIL (Cat)Modality=Multimodal, Fusion Strategy=Concatenation, Magnification=20x, Pathway Sets=Reactome and Hallmark2023.040.569
ABMIL (Cat)Modality=Multimodal, Fusion Strategy=Concatenation, Magnification=20x, Pathway Sets=Reactome and Hallmark2023.040.56
TransMILModality=WSI, Magnification=20x2023.040.556
ABMILModality=WSI, Magnification=20x2023.040.554
SNNModality=Omics, Magnification=20x, Pathway Sets=Reactome and Hallmark2023.040.55
S-MLPModality=Omics, Magnification=20x, Pathway Sets=Reactome and Hallmark2023.040.549
AMISL (KP)Modality=Multimodal, Fusion Strategy=Kronecker product, Magnification=20x, Pathway Sets=Reactome and Hallmark2023.040.544
AMISLModality=WSI, Magnification=20x2023.040.508
AMISL (Cat)Modality=Multimodal, Fusion Strategy=Concatenation, Magnification=20x, Pathway Sets=Reactome and Hallmark2023.040.501